CeriBell, Inc. Common Stock (CBLL)

Price$21.13

Favorite Metrics

Price vs S&P 500 (26W)68.58%

Price vs S&P 500 (4W)5.05%

Market Capitalization$797.62M

All Metrics

Book Value / Share (Quarterly)$4.14

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)50.90%

Cash Flow / Share (Quarterly)$-1.13

Price vs S&P 500 (YTD)-7.51%

Gross Margin (TTM)87.89%

Net Profit Margin (TTM)-59.97%

EPS (TTM)$-1.46

10-Day Avg Trading Volume0.24M

EPS Excl Extra (TTM)$-1.46

EPS (Annual)$-1.46

ROI (Annual)-30.50%

Gross Margin (Annual)87.89%

Cash / Share (Quarterly)$4.25

Revenue Growth QoQ (YoY)33.72%

ROA (Last FY)-27.28%

EBITD / Share (TTM)$-1.37

Operating Margin (TTM)-65.57%

Cash Flow / Share (Annual)$-1.13

P/B Ratio5.13x

P/B Ratio (Quarterly)5.24x

Net Income / Employee (Annual)$-0

EV / Revenue (TTM)8.72x

Net Interest Coverage (TTM)-27.26x

ROA (TTM)-26.17%

EPS Incl Extra (Annual)$-1.46

Current Ratio (Annual)9.73x

Quick Ratio (Quarterly)9.20x

3-Month Avg Trading Volume0.37M

52-Week Price Return46.24%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)8.96x

Asset Turnover (Annual)0.45x

52-Week High$24.33

EPS Excl Extra (Annual)$-1.46

26-Week Price Return77.32%

Quick Ratio (Annual)9.20x

13-Week Price Return-7.59%

Total Debt / Equity (Annual)0.13x

Current Ratio (Quarterly)9.73x

Enterprise Value$776.953

Asset Turnover (TTM)0.44x

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)1.52x

Pretax Margin (Annual)-59.97%

Cash / Share (Annual)$4.25

3-Month Return Std Dev39.39%

Net Income / Employee (TTM)$-0

ROE (Last FY)-34.38%

Net Interest Coverage (Annual)-27.26x

EPS Basic Excl Extra (Annual)$-1.46

Receivables Turnover (TTM)5.94x

Total Debt / Equity (Quarterly)0.13x

EPS Incl Extra (TTM)$-1.46

Receivables Turnover (Annual)5.94x

ROI (TTM)-28.44%

P/S Ratio (TTM)8.96x

Revenue / Share (Annual)$2.44

Price vs S&P 500 (52W)11.14%

Year-to-Date Return-3.37%

5-Day Price Return10.71%

EPS Normalized (Annual)$-1.46

Net Profit Margin (Annual)-59.97%

Month-to-Date Return15.60%

EBITD / Share (Annual)$-1.37

Operating Margin (Annual)-65.57%

LT Debt / Equity (Annual)0.13x

LT Debt / Equity (Quarterly)0.13x

EPS Basic Excl Extra (TTM)$-1.46

P/B Ratio (Annual)5.24x

Inventory Turnover (TTM)1.52x

Pretax Margin (TTM)-59.97%

Book Value / Share (Annual)$4.14

Price vs S&P 500 (13W)-10.45%

Beta1.40x

Revenue / Share (TTM)$2.40

ROE (TTM)-31.77%

52-Week Low$10.85

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.43

Industry Peers — Electromedical Equipment(29)

Symbol	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
CBLLCeriBell, Inc. Common Stock	8.96x	—	87.89%	-65.57%	$21.13
MDTMedtronic plc	3.13x	3.01%	65.16%	17.00%	$85.00
MASIMasimo Corporation	6.11x	5.95%	61.90%	20.30%	$178.45
TMDXTransMedics Group, Inc. Common Stock	6.56x	88.21%	59.92%	17.93%	$113.13
LIVNLivaNova PLC Ordinary Shares	2.59x	8.24%	68.04%	14.09%	$65.81
ITGRInteger Holdings Corporation	1.66x	11.55%	27.39%	11.90%	$89.32
AXGNAxogen, Inc. Common Stock	8.90x	14.93%	74.31%	-3.49%	$37.23
CNMDCONMED Corporation	0.88x	9.77%	54.59%	7.46%	$39.68
BLFSBioLife Solutions Inc.	10.84x	14.87%	64.56%	-17.26%	$22.19
INMDInMode Ltd. Ordinary Shares	2.51x	12.45%	78.54%	23.05%	$14.57
CVCapsoVision, Inc. Common Stock	22.10x	—	52.92%	-188.25%	$6.01

About

CeriBell Inc. develops portable point-of-care EEG systems for rapid neurological diagnosis in acute care settings. The company's Ceribell System combines proprietary hardware with AI algorithms to address critical diagnostic needs. Products include Point-of-Care EEG devices, Clarity analytics software, and the EEG Portal platform.